[1]
|
PBPK Modeling of PAXLOVIDTM: Incorporating Rotamer Conversion Kinetics to Advanced Dissolution and Absorption Model
Journal of Pharmaceutical Sciences,
2024
DOI:10.1016/j.xphs.2023.09.028
|
|
|
[2]
|
Synthesis and characterization of C2-symmetric bis(carboxamide) pincer ligands
New Journal of Chemistry,
2024
DOI:10.1039/D3NJ05502G
|
|
|
[3]
|
Enantioselective Synthesis of Heteroatom‐Linked Non‐Biaryl Atropisomers
Angewandte Chemie International Edition,
2024
DOI:10.1002/anie.202407767
|
|
|
[4]
|
Enantioselective Synthesis of Heteroatom‐Linked Non‐Biaryl Atropisomers
Angewandte Chemie International Edition,
2024
DOI:10.1002/anie.202407767
|
|
|
[5]
|
Enantioselective Synthesis of Heteroatom‐Linked Non‐Biaryl Atropisomers
Angewandte Chemie,
2024
DOI:10.1002/ange.202407767
|
|
|
[6]
|
Atropisomerism transforming
anti‐cancer
drug discovery
Chemical Biology & Drug Design,
2023
DOI:10.1111/cbdd.14155
|
|
|
[7]
|
Atropisomerism transforming
anti‐cancer
drug discovery
Chemical Biology & Drug Design,
2023
DOI:10.1111/cbdd.14155
|
|
|
[8]
|
High-Level Data Fusion Enables the Chemoinformatically Guided Discovery of Chiral Disulfonimide Catalysts for Atropselective Iodination of 2-Amino-6-arylpyridines
Journal of the American Chemical Society,
2022
DOI:10.1021/jacs.2c08820
|
|
|
[9]
|
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe
Journal of Medicinal Chemistry,
2022
DOI:10.1021/acs.jmedchem.2c00441
|
|
|
[10]
|
High-Level Data Fusion Enables the Chemoinformatically Guided Discovery of Chiral Disulfonimide Catalysts for Atropselective Iodination of 2-Amino-6-arylpyridines
Journal of the American Chemical Society,
2022
DOI:10.1021/jacs.2c08820
|
|
|
[11]
|
Atropisomerism transforming
anti‐cancer
drug discovery
Chemical Biology & Drug Design,
2022
DOI:10.1111/cbdd.14155
|
|
|
[12]
|
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe
Journal of Medicinal Chemistry,
2022
DOI:10.1021/acs.jmedchem.2c00441
|
|
|